Carlo Notaristefani Teva Pharmaceutical Industries Limited CEO Rating

Teva Pharmaceutical Industries Limited CEO Carlo Notaristefani Bio

Dr. Carlo De Notaristefani, Ph.D., serves as Executive Vice President of Global Operations at Teva Pharmaceutical Industries Limited. Dr. De Notaristefani served as Chief Executive Officer and President of Global Operations at Teva Pharmaceutical Industries Limited since August 2012. Dr. De Notaristefani has responsibility for Teva's product supply and its manufacturing network and ensure that Teva exceeds the highest standards in executing an integrated supply chain operation on a global level. He served as President of Technical Operations and Global Support Functions at Bristol-Myers Squibb Co. since March 3, 2009 and served as its Member of Management Council. He was responsible for Bristol-Myers Squibb Technical Operations organization, which meets Bristol-Myers Squibb Co.'s complex manufacturing challenges. He served as President of Technical Operations, Worldwide Pharmaceuticals division at Bristol-Myers Squibb Co. from 2004 to March 2009 and served as its President of Pharmaceutical Group & Technical Operations division from 2004 to 2004. He served as a Vice President of IO International of Aventis Pharma from 2000 to 2001. He served as Vice President of IO International of Latin America and Japan of Aventis Pharma from 2001 to 2003. He also served as a Senior Vice President of Global Finishing Solids of Aventis Pharma from 2003 to 2004. He was with Hoechst Marion Roussel, Marion Merrell Dow and Dow Chemical. He has over 25 years of international experience with extensive technical, operational, manufacturing and P&L experience. He has been a Director of Medarex, Inc. He is a Certified Professional Engineer. Dr. De Notaristefani received his PhD in chemical engineering, summa cum laude from University of Naples -- Naples, Italy.

Teva Pharmaceutical Industries Limited CEO Carlo Notaristefani At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Teva Pharmaceutical Industries Limited.

Overall, the CEO score has remained stable over the last 90 days.